Health Catalyst, Inc.

Health Catalyst, Inc.

HCATNYSE / NASDAQHealthcareSmall cap

$1.31+$0.02 (+1.6%)

Last close · Data as of Nov 20, 2026

Market cap
$143.4M
P/E
-0.8x
EV / EBITDA
-2.6x
Revenue
$311.1M
Net margin
-57.2%
ROCE
-10.3%

-35.5% over the last year

Health Catalyst, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-25.1%
3M
-19.6%
6M
+1.6%
1Y
-35.5%
5Y
-97.2%

52-week range

Day change +$0.02 (+1.6%) from $1.29 to $1.31 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in HCAT, bought on each weekday since 2021.

News & filings

What Health Catalyst filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 178 million US dollars in fiscal 2025.

Strengths (1)

  • Cash on the balance sheet equals 35% of the company's market value.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services.

Read moreShow less

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Sector
Healthcare
Shares outstanding
72.0M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$143.4M
P/E
-0.8x
P/B
0.6x
EV / EBITDA
-2.6x
EV / Sales
0.8x
P/S
0.5x
52-week high
$2.99
52-week low
$1.00

Profitability

Operating margin
-13.7%
Net margin
-57.2%
EBITDA margin
-32.9%
ROE
-72.4%
ROCE
-10.3%
ROIC
-33.0%
ROA
-35.4%
Asset turnover
0.62

Growth

Revenue
$311.1M
Revenue growth, 1Y
1.5%
Revenue CAGR, 3Y
4.0%
Net profit growth, 1Y
156.1%
Free cash flow
-$20.8M

Solvency

Current ratio
1.89
Debt / Equity
0.70
Debt / Assets
0.34
CFO / Net profit
-0.00
Cash / Market cap
35.4%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$311.1M
Cost of revenue$159.5M
Gross profit$151.7M
Operating expenses$194.4M
Research and development$49.8M
Selling, general and administrative$94.2M
Operating income-$42.7M
Interest and other-$134.5M
Pretax income-$177.3M
Tax and other$710.0k
Net income-$178.0M

Revenue and net profit

Revenue grew 1.5% in FY2025; net profit is the dashed line.

Health Catalyst, Inc. revenue and net profit by fiscal year
Health Catalyst, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$276.2M-$137.4M
FY2023$295.9M-$118.1M
FY2024$306.6M-$69.5M
FY2025$311.1M-$178.0M

Cash flows

FY2025: $731.0k from operations, -$20.8M free after investment (dashed).

Health Catalyst, Inc. operating and free cash flow by fiscal year
Health Catalyst, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022-$35.3M-$52.7M
FY2023-$33.1M-$47.4M
FY2024$14.6M-$1.8M
FY2025$731.0k-$20.8M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$311.1M+1.5%1Y
EBITDA
-$102.5M
Net profit
-$178.0M
Cash from operations
$731.0k-95.0%1Y
Free cash flow
-$20.8M
Revenue CAGR, 3Y
4.0%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$311.1M-$102.5M-$178.0M-$20.8M-72.4%+1.5%+156.1%

Monthly returns

Month-by-month returns of HCAT across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$502.6M
Liabilities$256.9M
Equity$245.8M
Retained earnings-$1.4B

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; HCAT highlighted.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

  1. Health Catalyst, Inc. (this company)0.8x

Not shown (no positive earnings and no EV / Sales): TuHURA Biosciences, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Health Catalyst, Inc.HCATthis company$143.4M-0.8x0.6x-72.4%-2.6x
Protalix BioTherapeutics, Inc.PLX$161.9M—3.4x-13.7%—
Korro Bio, Inc.KRRO$161.2M-1.4x3.1x-228.0%-2.2x
CVRx, Inc.CVRX$156.0M—4.0x-135.6%—
Nano-X Imaging Ltd.NNOX$144.1M-1.9x1.0x-53.7%-2.1x
TuHURA Biosciences, Inc.HURA$139.5M-4.6x6.8x-145.5%-4.7x
AVITA Medical, Inc.RCEL$134.2M-2.8x-8.1x291.8%-4.1x
SANUWAVE Health, Inc.SNWV$132.3M11.2x81.7x729.6%7.4x
MaxCyte, Inc.MXCT$131.8M-3.0x0.8x-26.0%-3.2x
Peer median—-2.3x3.2x-39.9%-2.7x

Year-to-date ROI

HCAT since 1 January, against earlier years.

Historical volatility

HCAT's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Health Catalyst, Inc. operating margin by fiscal year
Health Catalyst, Inc. operating margin by fiscal year
DateOperating margin
FY2022-50.7%
FY2023-33.8%
FY2024-18.8%
FY2025-13.7%
LineFY2025
Cost of revenueCost Of Revenue$159.5M
Gross profitGross Profit$151.7M
Operating expensesOperating Expense$194.4M
Research and developmentResearch And Development$49.8M
Depreciation and amortisationDepreciation And Amortization In Income Statement$50.5M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$50.5M
Total expensesTotal Expenses$353.9M
Pretax incomePretax Income-$177.3M

Learn while you research

Academy chapters picked for Health Catalyst, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →